Figure 3.
Measurement of circulating cells and biomarkers in tumor-bearing mice. Plasma levels of active human (A, n = 6 and 4) and active mouse (B, n = 10 and 4) plasminogen activator inhibitor 1 (PAI-1), and thrombin-antithrombin (TAT) complexes (C, n = 8 and 8) were measured using commercial assays. Levels of neutrophils (D, n = 8 and 8) and platelets (E, n = 8 and 8) are shown. Data are shown as mean ± standard deviation. Data were analyzed with either the Welch t test (A-B) or the unpaired, 2-tailed Student t test (C-E) depending on the variances (*P < .05, **P < .01).

Measurement of circulating cells and biomarkers in tumor-bearing mice. Plasma levels of active human (A, n = 6 and 4) and active mouse (B, n = 10 and 4) plasminogen activator inhibitor 1 (PAI-1), and thrombin-antithrombin (TAT) complexes (C, n = 8 and 8) were measured using commercial assays. Levels of neutrophils (D, n = 8 and 8) and platelets (E, n = 8 and 8) are shown. Data are shown as mean ± standard deviation. Data were analyzed with either the Welch t test (A-B) or the unpaired, 2-tailed Student t test (C-E) depending on the variances (*P < .05, **P < .01).

Close Modal

or Create an Account

Close Modal
Close Modal